Medicine guide

Dexmedetomidine Baxter 200 μg/2 ml

As listed in the register: Dexmedetomidine Baxter 200 μg/2 ml, Konzentrat zur Herstellung einer Infusionslösung

200 μg/2 ml ·

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Dexmedetomidinum
Made by
Baxter AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Sedierung erwachsener, intensivmedizinisch behandelter Patienten sowie Sedierung erwachsener, nicht intubierter Patienten vor und/oder während diagnostischer oder chirurgischer Massnahmen.

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byBaxter AG
Active substanceDexmedetomidinum
Used inPain, sleep, mood, epilepsy and the brain
Strength200 μg/2 ml
ClassificationN05CM18 · Pain, sleep, mood, epilepsy and the brain
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerDexmedetomidine Baxter 200 μg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
Packs5 Durchstechflasche(n)
Zulassungsnummer68249
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.